• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外膜肺氧合时获得医院血流感染的预测因素。

Predictors of acquiring a nosocomial bloodstream infection on extracorporeal membrane oxygenation.

作者信息

Steiner C K, Stewart D L, Bond S J, Hornung C A, McKay V J

机构信息

Division of Neonatology, Department of Pediatrics, Center for Health Services and Policy Research, University of Louisville School of Medicine, Louisville, KY 40202-3830, USA.

出版信息

J Pediatr Surg. 2001 Mar;36(3):487-92. doi: 10.1053/jpsu.2001.21609.

DOI:10.1053/jpsu.2001.21609
PMID:11227003
Abstract

PURPOSE

The aim of this study was to identify independent predictors of acquiring a nosocomial bloodstream infection (BSI) during extracorporeal membrane oxygenation (ECMO).

METHODS

This retrospective cohort consisted of 202 neonates treated with ECMO from 1989 to 1998 at the author' institution. Data collected included patient demographics, primary and secondary diagnoses, white blood cell counts, antibiotic usage, presence of central lines, operative procedures, and outcome. Surveillance blood cultures were drawn daily from the circuit using sterile technique to identify acquired pathogens. Statistical analyses included logistic regression, Cox proportional regression analysis, and discriminate analysis.

RESULTS

There were 1,245 blood cultures drawn on 202 patients (6.2 cultures per patient), and a nosocomial BSI was identified in 7 patients (3.4%) during this 10-year span. These were infections that were neither present nor incubating on admission. Pre-ECMO diagnoses of patients who had a nosocomial BSI while on bypass included group B beta-hemolytic streptococcal sepsis (n = 2), herpes simplex viral sepsis (n = 1), congenital diaphragmatic hernia (n = 2), persistent pulmonary hypertension (n = 1), and congenital heart disease (n = 1). The median time on ECMO before obtaining a positive culture was 390 hours. The infectious agents responsible for these BSIs included Staphylococcus epidermidis (n = 5), Staphylococcus aureus (n = 1), and Escherichia coli (n = 1). The major factor associated with acquiring a nosocomial BSI on ECMO was the duration of bypass (391 v 141 hours, P =.002). Additionally, patients in the BSI group were more likely to have had an arterial catheter in place (16 v 7 days, P =.009) and to have received more screening blood cultures (16 v 6 cultures, P < 001). White blood cell counts, absolute neutrophil counts, and immature/total (I/T) ratios were not useful in predicting a nosocomial BSI. Of the 31 patients who required ECMO for more than 10 days, 7 (23%) had a positive blood culture, and 5 of these 7 infants (71%) died (P =.03).

CONCLUSIONS

The only predictor of acquiring a nosocomial BSI on ECMO was the duration of support for greater than 10 days. Because classical predictors of infection are unreliable while the patient is on ECMO, the authors suggest that obtaining daily surveillance blood cultures beginning on the tenth day should be performed with prolonged ECMO courses. The authors confirmed previous reports of the association between a prolonged ECMO course and a high mortality rate. However, the authors speculate that, in actuality, the primary diagnosis leads to the prolonged course of support and is the major factor in the infant' demise.

摘要

目的

本研究旨在确定体外膜肺氧合(ECMO)期间获得医院血流感染(BSI)的独立预测因素。

方法

该回顾性队列研究包括1989年至1998年在作者所在机构接受ECMO治疗的202例新生儿。收集的数据包括患者人口统计学、原发性和继发性诊断、白细胞计数、抗生素使用情况、中心静脉置管情况、手术操作及结局。采用无菌技术每天从循环管路采集监测血培养标本以鉴定获得性病原体。统计分析包括逻辑回归、Cox比例回归分析和判别分析。

结果

对202例患者共采集了1245份血培养标本(平均每名患者6.2份),在这10年期间7例患者(3.4%)被鉴定为医院BSI。这些感染在入院时既不存在也未处于潜伏期。在体外循环期间发生医院BSI的患者,其ECMO前诊断包括B族β溶血性链球菌败血症(n = 2)、单纯疱疹病毒败血症(n = 1)、先天性膈疝(n = 2)、持续性肺动脉高压(n = 1)和先天性心脏病(n = 1)。获得阳性培养结果前ECMO的中位时间为390小时。导致这些BSI的病原体包括表皮葡萄球菌(n = 5)、金黄色葡萄球菌(n = 1)和大肠杆菌(n = 1)。与在ECMO上获得医院BSI相关的主要因素是体外循环时间(391小时对141小时,P = 0.002)。此外,BSI组患者更可能留置动脉导管(16天对7天,P = 0.009)且接受更多的筛查血培养(16次对6次培养,P < 0.001)。白细胞计数、绝对中性粒细胞计数和未成熟/总(I/T)比值对预测医院BSI无用。在31例需要ECMO支持超过10天的患者中,7例(23%)血培养阳性,这7例婴儿中有5例(71%)死亡(P = 0.03)。

结论

在ECMO上获得医院BSI的唯一预测因素是支持时间超过1〇天。由于在患者接受ECMO期间传统的感染预测指标不可靠,作者建议对于延长的ECMO疗程,应从第10天开始每天进行监测血培养。作者证实了先前关于延长ECMO疗程与高死亡率之间关联的报道。然而,作者推测,实际上,原发性诊断导致了延长的支持疗程,并且是婴儿死亡的主要因素。

相似文献

1
Predictors of acquiring a nosocomial bloodstream infection on extracorporeal membrane oxygenation.体外膜肺氧合时获得医院血流感染的预测因素。
J Pediatr Surg. 2001 Mar;36(3):487-92. doi: 10.1053/jpsu.2001.21609.
2
Central venous catheter placement at the time of extracorporeal membrane oxygenation decannulation: is it safe?体外膜肺氧合撤管时行中心静脉导管置入:是否安全?
J Pediatr Surg. 2008 Jan;43(1):53-7; discussion 58. doi: 10.1016/j.jpedsurg.2007.09.018.
3
Risk factors for nosocomial infection during extracorporeal membrane oxygenation.体外膜肺氧合期间医院感染的危险因素。
J Hosp Infect. 2009 Nov;73(3):210-6. doi: 10.1016/j.jhin.2009.07.016. Epub 2009 Sep 25.
4
Healthcare-associated infection in pediatric patients on extracorporeal life support: The role of multidisciplinary surveillance.接受体外生命支持的儿科患者的医疗相关感染:多学科监测的作用。
Pediatr Crit Care Med. 2006 Nov;7(6):546-50. doi: 10.1097/01.PCC.0000243748.74264.CE.
5
Nosocomial bloodstream infections in ICU and non-ICU patients.重症监护病房(ICU)和非ICU患者的医院血流感染
Am J Infect Control. 2005 Aug;33(6):333-40. doi: 10.1016/j.ajic.2005.03.010.
6
Nosocomial catheter-related bloodstream infections in a pediatric intensive care unit: risk and rates associated with various intravascular technologies.儿科重症监护病房中医院导管相关血流感染:与各种血管内技术相关的风险和发生率
Pediatr Crit Care Med. 2003 Oct;4(4):432-6. doi: 10.1097/01.PCC.0000090286.24613.40.
7
Study of nosocomial primary bloodstream infections in a pediatric intensive care unit.儿科重症监护病房医院原发性血流感染的研究
J Trop Pediatr. 2007 Apr;53(2):87-92. doi: 10.1093/tropej/fml073. Epub 2006 Dec 6.
8
Extracorporeal membrane oxygenation for cardiopulmonary failure in pediatric patients: is a second course justified?小儿心肺衰竭的体外膜肺氧合:再次治疗是否合理?
J Surg Res. 2008 Jul;148(1):100-8. doi: 10.1016/j.jss.2008.03.023. Epub 2008 Apr 10.
9
Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy.体外膜肺氧合治疗幸存者中与感音神经性听力损失相关的因素。
Pediatrics. 2005 Jun;115(6):1519-28. doi: 10.1542/peds.2004-0247.
10
[Risk factors for nosocomial bloodstream infections in a neonatal intensive care unit].[新生儿重症监护病房医院血流感染的危险因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2010 Aug;12(8):622-4.

引用本文的文献

1
Hospital-acquired infections in neonatal ECMO patients: a systematic review and meta-analysis.新生儿体外膜肺氧合(ECMO)患者的医院获得性感染:一项系统评价和荟萃分析。
Ital J Pediatr. 2025 Jun 9;51(1):182. doi: 10.1186/s13052-025-02044-1.
2
Use of standardized nasal and skin decolonization to reduce rates of bacteremia in patients undergoing extracorporeal membrane oxygenation.使用标准化的鼻腔和皮肤去定植以降低接受体外膜肺氧合治疗患者的菌血症发生率。
Antimicrob Steward Healthc Epidemiol. 2025 Feb 12;5(1):e41. doi: 10.1017/ash.2025.9. eCollection 2025.
3
Mechanical Assist Device-Assisted Percutaneous Coronary Intervention: The Use of Impella Versus Extracorporeal Membrane Oxygenation as an Emerging Frontier in Revascularization in Cardiogenic Shock.
机械辅助装置辅助经皮冠状动脉介入治疗:在心源性休克血管重建中使用Impella与体外膜肺氧合作为一个新的前沿领域。
Cureus. 2023 Jan 4;15(1):e33372. doi: 10.7759/cureus.33372. eCollection 2023 Jan.
4
Clearance of blood stream infections in patients receiving extracorporeal membrane oxygenation: a retrospective single-center cohort study.体外膜肺氧合患者血流感染清除率:一项回顾性单中心队列研究。
BMC Infect Dis. 2023 Feb 2;23(1):63. doi: 10.1186/s12879-023-08021-5.
5
Risk factors for bloodstream infection (BSI) in patients with severe acute respiratory distress syndrome (ARDS) supported by veno-venous extracorporeal membrane oxygenation (VV-ECMO).VV-ECMO 支持下的严重急性呼吸窘迫综合征(ARDS)患者发生血流感染(BSI)的危险因素。
BMC Pulm Med. 2022 Sep 28;22(1):370. doi: 10.1186/s12890-022-02164-y.
6
Role and Clinical Application of Metagenomic Next-Generation Sequencing in Immunocompromised Patients With Acute Respiratory Failure During Veno-Venous Extracorporeal Membrane Oxygenation.宏基因组下一代测序在免疫抑制患者静脉-静脉体外膜肺氧合治疗急性呼吸衰竭中的作用及临床应用。
Front Cell Infect Microbiol. 2022 Aug 12;12:877205. doi: 10.3389/fcimb.2022.877205. eCollection 2022.
7
Nosocomial Infections in Nonsurgical Patients Undergoing Extracorporeal Membrane Oxygenation: A Retrospective Analysis in a Chinese Hospital.接受体外膜肺氧合治疗的非手术患者的医院感染:一家中国医院的回顾性分析
Infect Drug Resist. 2022 Jul 29;15:4117-4126. doi: 10.2147/IDR.S372913. eCollection 2022.
8
Nosocomial Infections During Extracorporeal Membrane Oxygenation in Pediatric Patients: A Multicenter Retrospective Study.小儿患者体外膜肺氧合期间的医院感染:一项多中心回顾性研究
Front Pediatr. 2022 Jun 13;10:873577. doi: 10.3389/fped.2022.873577. eCollection 2022.
9
Diagnostic Accuracy of Infection Markers to Diagnose Infections in Neonates and Children Receiving Extracorporeal Membrane Oxygenation.用于诊断接受体外膜肺氧合治疗的新生儿和儿童感染的感染标志物的诊断准确性
Front Pediatr. 2022 Jan 26;9:824552. doi: 10.3389/fped.2021.824552. eCollection 2021.
10
Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock.静脉-动脉体外膜肺氧合(VA-ECMO)支持治疗心源性休克概述
Front Cardiovasc Med. 2021 Jul 7;8:686558. doi: 10.3389/fcvm.2021.686558. eCollection 2021.